Thalys Medical Technology Group (SHSE:603716) Long-Term Capital Lease Obligation : ¥27 Mil (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Thalys Medical Technology Group Long-Term Capital Lease Obligation?

Thalys Medical Technology Group's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥27 Mil.

Thalys Medical Technology Group's quarterly Long-Term Capital Lease Obligation declined from Sep. 2024 (¥32 Mil) to Dec. 2024 (¥26 Mil) but then increased from Dec. 2024 (¥26 Mil) to Mar. 2025 (¥27 Mil).

Thalys Medical Technology Group's annual Long-Term Capital Lease Obligation increased from Dec. 2022 (¥32 Mil) to Dec. 2023 (¥33 Mil) but then declined from Dec. 2023 (¥33 Mil) to Dec. 2024 (¥26 Mil).

Thalys Medical Technology Group Long-Term Capital Lease Obligation Historical Data

The historical data trend for Thalys Medical Technology Group's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thalys Medical Technology Group Long-Term Capital Lease Obligation Chart

Thalys Medical Technology Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

27.96

47.48

31.74

32.87

25.86

Thalys Medical Technology Group Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															31.74	34.90	32.44	25.86	26.55

Thalys Medical Technology Group (SHSE:603716) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Thalys Medical Technology Group Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Thalys Medical Technology Group's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Thalys Medical Technology Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thalys Medical Technology Group Corp (SHSE:603716) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

1310 Jinshan Avenue, Dongxihu District, Hubei Province, Wuhan, CHN, 430040

Website

https://www.thalys.net.cn

Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.

Executives

Wang Jun Ming	senior management
Wang Zheng	senior management
Wang Wen Bin	senior management
Liu Wen Hao	Director
Huang Yong Xi	senior management
Lei Xian Kun	Director
Fan Li	Director
Liu Yuan	senior management
Wan Li Bo	senior management
Wen Wei	Director
Chou Jian	senior management
Song Yu	Director

Thalys Medical Technology Group Headlines

No Headlines